Key2Brain

Private

SolnaHealthcare & Life Scienceshttps://www.key2brain.com/

Last Round

Grant

Apr 1, 2026

Total Funding Raised

$464,300

Company Overview

Key2Brain is a biotechnology company that provides a platform technology for enhanced brain uptake of biologics and diagnostics for treating the central nervous system (CNS).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

blood-brain barrier shuttleBBB shuttlebrain drug deliverybrain shuttledrug delivery platformVHH antibodiesnanobodiesCNS drug deliverysingle-domain antibodiesTransferrin Receptor targetingTfR targetingCNS therapeuticsbiotech licensingoligonucleotide deliverysiRNA deliverylysosomal storage disordersAlzheimer's disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Key2Brain Comps

Public and private peers based on sector, stage, and business model.

Key2Brain comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Key2Brain Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Apr 1, 2026
VC Round	Oct 2, 2024
Grant	Nov 1, 2023
Grant	May 18, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Magnus Berglund

Chief Technology Officer

Executive Team

Key2Brain Investors

Notable investors and investment history

Key2Brain investors
Investor	Rounds
Uppsala Innovation Centre	Accelerator
Phase2Phase Biopharma	VC Round, Accelerator
Vinnova	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 4, 2025
Grew 57% QoQ, from 7 to 11 employees.
Apr 11, 2025
Grew 43% QoQ, from 7 to 10 employees.

View all signals

Key2Brain Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Key2Brain Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Key2Brain's valuation, stock price, and market status.

Firmographic Details

HeadquartersSolna

Employee Range14

Year Founded2020

Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.